Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Inventory (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Inventory for 6 consecutive years, with $36.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory fell 8.21% year-over-year to $36.0 million, compared with a TTM value of $36.0 million through Dec 2025, down 8.21%, and an annual FY2025 reading of $36.0 million, down 8.21% over the prior year.
  • Inventory was $36.0 million for Q4 2025 at Treace Medical Concepts, down from $41.4 million in the prior quarter.
  • Across five years, Inventory topped out at $43.6 million in Q3 2024 and bottomed at $7.4 million in Q1 2021.
  • Average Inventory over 5 years is $26.1 million, with a median of $27.7 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 102.65% in 2023, then fell 8.21% in 2025.
  • Year by year, Inventory stood at $10.6 million in 2021, then soared by 83.03% to $19.3 million in 2022, then skyrocketed by 51.29% to $29.2 million in 2023, then skyrocketed by 34.23% to $39.3 million in 2024, then fell by 8.21% to $36.0 million in 2025.
  • Business Quant data shows Inventory for TMCI at $36.0 million in Q4 2025, $41.4 million in Q3 2025, and $42.4 million in Q2 2025.